June 29, 2017 / 12:35 PM / in 23 days

BRIEF-Imprimis Pharmaceuticals sells Pennsylvania facility and sinus assets

1 Min Read

June 29 (Reuters) - Imprimis Pharmaceuticals Inc

* Imprimis Pharmaceuticals sells Pennsylvania facility and sinus assets

* It has entered into an agreement to sell its Folcroft, Pennsylvania facility and sinus related assets for $450,000. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below